| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |